About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

TNRCoverWeb120.jpg Buy on Amazon

Brain Waves

Monthly Archives

October 30, 2009

Opportunities in Neuroscience for Future Army Applications

Email This Entry

Posted by Zack Lynch

9780309127400.jpgFloyd Bloom and team have done all of us a service with this extensively researched and well thought out analysis. I'm using the findings right now on a new piece of legislation in development. Opportunities in Neuroscience for Future Army Applications makes 17 recommendations that focus on utilizing current scientific research and development initiatives to improve performance and efficiency, collaborating with pharmaceutical companies to employ neuropharmaceuticals for general sustainment or enhancement of soldier performance, and improving cognitive and behavioral performance using interdisciplinary approaches and technological investments. An essential guide for the Army, this book will also be of interest to other branches of military, national security and intelligence agencies, academic and commercial researchers, pharmaceutical companies, and others interested in applying the rapid advances in neuroscience to the performance of individual and group tasks.

Comments (0) + TrackBacks (0) | Category: Neurowarfare

October 22, 2009

Neurotech Clusters: Leading Regions in the Global Neurotechnology Industry

Email This Entry

Posted by Zack Lynch

sf.jpgThis reports really represents the economic geographer in me wondering how the neurotech industry is developing across space. After months of data collection, writing and analysis here are the results. Go to the NIO website to download the 100 page report.

According to NeuroInsights and NIO, the top nine neurotech regions with composite scores are:
1. San Francisco Bay Area, CA (100)
2. Greater Boston, MA (98)
3. New York/New Jersey (91)
4. London, United Kingdom (84)
5. San Diego, CA (83)
6. Los Angeles/Irvine, CA (81)
7. Baltimore, MD (69)
8. Greater Philadelphia, PA (66)
9. Minneapolis, MN (53)

Other regions supporting neurotech innovation include nascent clusters (Montreal, Canada; Basel/Zurich, Switzerland; Tel Aviv, Israel; Seattle, WA; Stockholm, Sweden; Tokyo, Japan) as well as regions to watch (Munich, Germany; New Haven, CT; Chicago, IL; Shanghai, China, Cleveland, OH and Raleigh/Durham, NC).

The rankings are based on three broad factors: number of neuroscience-focused companies, availability of local risk capital and social infrastructure (universities, hospitals, research institutes). The San Francisco Bay Area ranked first in number of companies and risk capital, while Boston ranked first in social infrastructure.

Data gathered for the report also reveals several other interesting regional trends. New York/New Jersey is the leading region for public neurotechnology companies. Boston, MA and Baltimore/Washington D.C. are the leading regions for neurotechnology social infrastructure based on strong graduate programs and hospital rankings in neuroscience related areas. The San Francisco Bay Area, Minneapolis, MN and Cleveland, OH are major centers for neurodevice development.

A special thanks to Corey M. McCann, our bright and diligent intern for all his hard work on this project!

Comments (0) + TrackBacks (0) | Category: Neurotech Industry

October 14, 2009

The Young and the Neuro "Revolution"

Email This Entry

Posted by Zack Lynch

From prefix to adjective and now David Brooks makes "the Neuro" a noun. The meme lives.

Comments (0) + TrackBacks (0) | Category: Neuro Revolution

October 8, 2009

2010 Translational Neurotech Summit, Call For Speakers

Email This Entry

Posted by Zack Lynch

2010NDFSummit%20banner%20448.jpgThe Neurotech Development Foundation is organizing a Translational Neurotech Summit on May 18, 2010. This one day gathering of scientists, entrepreneurs, executives and investors will be held coordination with The 5th annual Neurotech Investing and Partnering Conference May 19-20, 2010. The goal of the summit is to facilitate the movement of promising neurotechnology (pharmaceuticals, biologics, cell-based therapeutics, devices and diagnostics) from universities, government labs and research institutes into the private sector.

Showcase your translational research project to potential investors and partners:
* Cutting edge research projects ready for investment or hand off to industry (preclinical or clinical)
* Pharmaceuticals, biologics, cell therapies, devices, and diagnostics
* Presenter abstracts accepted from October 1 through January 5, 2010
* Presenters notified by February 15 and coached on presentation, partnering, and start-up strategy
* Presentations selected based on quality of research, interest to industry, and fit with program
* Presentations will be 10 minutes plus Q&A with session panel

The summit will feature the top researchers from across translational neuroscience including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, and stroke. Download Fillable Presenter Submission Form

Steering Committee:
-Casey Lynch, Managing Director, NeuroInsights & President, Neurotech Development Foundation
-Frank Eeckman, MD, PhD Consultant, NeuroInsights
-Jill Heemskerk, PhD, Program Director, Office of Translational Research, NINDS/NIH
-Charles Jennings, PhD, Director of McGovern Institute Neurotechnology Program, MIT
-Zack Lynch, Executive Director, Neurotechnology Industry Organization
-Dan O'Connell, Managing Director, NeuroVentures Capital
-Gail Schechter, PhD, Director Center for Bioentrepreneurship at UCSF
-Paul Stypulkowski, PhD, Senior Director Research, Medtronic
-Guy Seabrook, PhD, Senior Director, Neuroscience Global External Research &
Development, Eli Lilly

The summit is hosted by the Neurotechnology Development Foundation, a 501(c)(3) nonprofit created to accelerate the development of treatments for the brain and nervous system by promoting translation of basic research.

Comments (0) + TrackBacks (0) | Category: NIO